Medical/Pharmaceuticals
Lumosa to Initiate Phase 2 Human Clinical Trial in the US and Taiwan for Its LT3001, A Novel Drug for the Treatment of Acute Ischemic Stroke
TAIPEI, , June 13, 2019 /PRNewswire/ -- Lumosa Therapeutics (Lumosa; code: 6535.TWO) announced that the company is ready to commence the Phase 2 proof of concept (PoC) study for its LT3001, a novel drug for the treatment of acute ischemic stroke (AIS) that showed good safety, tolerability and ...
2019-06-13 20:00
4397
Avalon GloboCare President and CEO David Jin, M.D., Ph.D. to Chair the "Research and Application of Stem Cell Exosomes" Session at This Year's Second International Aesthetic Industry Conference
Avalon GloboCare to Unveil the Launch of its Exosome Product Commercialization Plan at the Second Aesthetic Industry Conference, the Largest Aesthetics Conference Across Asia Yu Zhou, M.D., Ph.D., Co-CEO of Avalon's subsidiary GenExosome Technologies to provide keynote address FREEHOLD, New Jer...
2019-06-13 20:00
9569
Tessa Therapeutics and China-Singapore Guangzhou Knowledge City Form Landmark US$120 Million Joint Venture in China to Develop Innovative Cell Therapies for Cancer
* The partnership will leverage Tessa Therapeutics' global operational capabilities and cell therapy platform technologies to target prevalent cancers inChina * The joint venture will be the sole licensee of Tessa Therapeutics' cell therapies for research, development and commercialization in...
2019-06-13 07:15
2348
ISTH President Claire McLintock Receives Officer of the New Zealand Order of Merit on Queen's Birthday Honours List
Award Underscores McLintock's Service to the Fields of Haematology & Obstetrics CHAPEL HILL, North Carolina, June 13, 2019 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH) today announced that ISTH President Claire McLintock, MD, has received the award of Officer of t...
2019-06-13 02:00
1997
CartiHeal Enrolls the 200th Patient in Its Pivotal Clinical Study in San Diego, CA
KFAR SABA, Israel, June 12, 2019 /PRNewswire/ -- CartiHeal, developer of the Agili-C™ implant for treating cartilage and osteochondral defects in traumatic and osteoarthritic joints, successfully enrolled the 200th patient in the Agili-C™ IDE pivotal clinical study. Surgery was performed byScott ...
2019-06-12 20:38
2709
Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk in PIONEER 6 trial
SAN FRANCISCO, June 12, 2019 /PRNewswire/ -- Novo Nordisk today announced that the PIONEER 6 trial achieved its primary endpoint by demonstrating non-inferiority of major adverse cardiovascular events (MACE) with oral semaglutide compared with placebo, both in addition to standard of care. The p...
2019-06-12 02:45
2612
Amcor Completes Acquisition of Bemis, Creating the Global Leader in Consumer Packaging
CHICAGO and MELBOURNE, Australia, June 12, 2019 /PRNewswire/ -- Amcor today announces the successful completion of its acquisition of Bemis Company Inc., effective11 June 2019. The combined company will now operate as Amcor plc (Amcor), trading on the New York Stock Exchange under the ticker symb...
2019-06-12 02:26
3085
Amcor Completes Acquisition of Bemis, Creating the Global Leader in Consumer Packaging
CHICAGO and MELBOURNE, Australia, June 11, 2019 /PRNewswire/ -- Amcor today announces the successful completion of its acquisition of Bemis Company Inc., effective11 June 2019. The combined company will now operate as Amcor plc (Amcor), trading on the New York Stock Exchange under the ticker symb...
2019-06-11 21:46
3195
Centinel Spine Announces Partnership with Tiger Woods
NEW YORK, June 11, 2019 /PRNewswire/ -- Centinel Spine®, LLC, the largest privately-held spine company focused on anterior column reconstruction, today announced an important partnership with one of the most winning professional athletes of all time, Tiger Woods. This partnership brings together ...
2019-06-11 21:12
3750
Zeus Expands Portfolio with New Polyimide Family of Products
Products Include PI Tubing, PI Coated Wire, PI Glide™ Tubing, and PI Glide™ Coated Wire ORANGEBURG, South Carolina, June 11, 2019 /PRNewswire/ -- Zeus Industrial Products, Inc. (Zeus), a leading polymer solutions provider and material science innovator, has announced the introduction of a newpol...
2019-06-11 20:00
3129
Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2019 Financial Results
HONG KONG, June 11, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the fourth quarter and full year fiscal 2019 onTuesday, June 18, 2019, after the market close. The Company will host a conference call...
2019-06-11 19:00
13417
GT Apeiron Therapeutics launched by GT Healthcare Capital Partners signs with Exscientia
SHANGHAI, June 11, 2019 /PRNewswire/ -- GT Apeiron Therapeutics ("Apeiron"), a novel biotechnology company, was launched with the backing from GT Healthcare and associated investors. The company also entered into a drug discovery collaboration with Exscientia, which utilizes artificial intellige...
2019-06-11 16:00
1976
TauRx Recognized as a Technology Innovation Leader in the Neurodegenerative Disease Management Industry
ABERDEEN, Scotland and SINGAPORE, June 11, 2019 /PRNewswire/ -- TauRx, a leader
in neurodegenerative disease research, today announced that it is the recipient
of Frost & Sullivan's 2019 Asia Pacific Neurodegenerative Disease Management
Technology Innovation Award.
2019-06-11 08:00
2016
Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device
PLYMOUTH MEETING, Pennsylvania, June 10, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that the medical arm of the U.S. Defense Threat Reduction Agency (DTRA) will fund the further development of Inovio's new commercial intradermal delivery device. DTRA's Medical ...
2019-06-10 21:00
3003
Avalon GloboCare Announces Completion of Clinical-Grade Exosome Bio-Production Standardization with Launch of "ACTEX" Product Commercialization
This milestone marks a pivotal point in Avalon's pipeline, now allowing the company to enter its next phase of commercializing clinical-grade exosome products FREEHOLD, New Jersey, June 10, 2019 /PRNewswire/ -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based techn...
2019-06-10 20:00
7267
Collaborative Medicinal Development, LLC Reports that Lead Drug Shows Dose-Dependent Improvement in Parkinson's Disease
MILL VALLEY, California, June 10, 2019 /PRNewswire/ -- Collaborative Medicinal Development LLC ("CMD"), a privately-held biopharmaceutical company developing innovative therapies for neurodegenerative diseases, will report promising results from its phase 1, non-placebo controlled, dose-finding s...
2019-06-10 20:00
1780
Sihuan's Abstracts regarding Clinical Trial Progress of SGLT-2 Inhibitor Selected for Poster Presentation at the American Diabetes Association's Scientific Sessions
HONG KONG, June 10, 2019 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460), the largest cardio-cerebral vascular drug manufacturer in China's prescription drug market, announced that three abstracts regarding the clinical trial of the Group's patented innovative drug Janaglif...
2019-06-10 16:28
6886
Ping An Good Doctor Launches Groundbreaking 'Private Doctor' Service
Strategic Move to Introduce Customized Mobile Medical Services SHANGHAI, June 10, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited("Ping An Good Doctor", or the "Company"; stock code: 01833.HK), the world's leading one-stop healthcare ecosystem platform, has launched the...
2019-06-10 12:32
9115
CStone and Bayer announce global collaboration to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib
SUZHOU, China, June 9, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) today announced that the company has entered into a global clinical collaboration withChina focus with Bayer HealthCare LLC to evaluate the safety, tolerability, pharmacokinetics (PK) and antitumor activity ...
2019-06-10 09:30
7350
Oral semaglutide showed superior reductions in blood sugar vs Jardiance® and non-inferior blood sugar reductions vs Victoza® in adults with type 2 diabetes at 26 weeks
Abstracts 54-OR and 55-OR Secondary data at 52 weeks demonstrated statistically significant blood sugar reductions and statistically significant reduction of body weight vs both Jardiance® and Victoza® SAN FRANCISCO, June 8, 2019 /PRNewswire/ -- Findings presented today from two phase 3a clinic...
2019-06-08 23:45
2961
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 318 media titles]
2024-05-07 08:00
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 316 media titles]
2024-05-08 14:37
OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 309 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 295 media titles]
2024-05-08 16:44
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
15019
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
10431
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
9812
